AVALONBAY COMMUNITIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AVALONBAY COMMUNITIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.04B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.91B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.77B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.59B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.29B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.30B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $593.57M | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $587.61M | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $577.26M | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $566.18M | Feb 21, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.04M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $7.08M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $7.72M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $6.33M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $3.08M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $3.82M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $4.96M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $3.57M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.15M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $5.60M | Feb 22, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $1.08B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $928.83M | Feb 27, 2026 |
| FY2018 | Dec 31, 2018 | $974.53M | Feb 22, 2019 |
| FY2018 | Dec 31, 2017 | $876.92M | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $1.03B | Feb 22, 2019 |
| FY2017 | Dec 31, 2015 | $742.04M | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $683.57M | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $353.14M | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $423.87M | Feb 19, 2015 |
| FY2013 | Dec 31, 2011 | $440.45M | Mar 3, 2014 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.02B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.91B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.79B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.70B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.46B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.47B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.55B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.49B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.40B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.31B | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.67B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.61B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.56B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.42B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.20B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.22B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.32B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.30B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.26B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.16B | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.19B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $21.00B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $20.68B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $20.46B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $19.90B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $19.20B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $19.12B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $18.38B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $18.41B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $17.87B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.36B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $9.06B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $8.89B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.20B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $8.97B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $8.44B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $8.13B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $7.74B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $8.02B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $7.69B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.61B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.94B | Feb 27, 2026 |
| FY2023 | Dec 31, 2023 | $11.78B | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | $11.25B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $10.93B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $10.75B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $10.99B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $10.63B | Feb 21, 2020 |
| FY2014 | Dec 31, 2014 | $9.05B | Feb 19, 2015 |
| FY2014 | Dec 31, 2013 | $8.60B | Feb 19, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $371.16M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $591.25M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $478.16M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $485.22M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $240.82M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $126.02M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $282.91M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $350.78M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $188.61M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $94.90M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $187.23M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $108.58M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $397.89M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $613.19M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $420.25M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $216.98M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $39.69M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $91.66M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $67.09M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $214.99M | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.33B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $8.08B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.98B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $8.32B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $8.10B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $7.63B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $7.36B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $7.10B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $7.40B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $7.08B | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 5 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 5 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 21, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 140.08M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 142.25M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 142.03M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 139.92M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 139.75M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 139.53M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 140.64M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 139.66M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 138.09M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 137.33M | Feb 23, 2018 |